Terms: = Uterine cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL
111 results:
1. Cervical cancer Screening: A Review.
Perkins RB; Wentzensen N; Guido RS; Schiffman M
JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
[TBL] [Abstract] [Full Text] [Related]
2. TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
Shi K; Liu XL; Guo Q; Zhang YQ; Fan ST; Dai L; Jiang N; Li D
PLoS One; 2023; 18(7):e0285817. PubMed ID: 37478120
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors for recurrence of cervical intraepithelial neoplasia after loop electrosurgical excisional procedure in patients with positive margins.
Oh SH; Lee KB; Shin JW; Lee SH
J Obstet Gynaecol Res; 2023 Aug; 49(8):2102-2108. PubMed ID: 37277146
[TBL] [Abstract] [Full Text] [Related]
4. High MutS homolog 2 expression predicts poor prognosis and is related to immune infiltration in endometrial carcinoma.
Lu X; Ying Y; Zhang W; Li R; Zhang J
Cell Biol Int; 2023 Jan; 47(1):201-215. PubMed ID: 36208091
[TBL] [Abstract] [Full Text] [Related]
5. Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA; Tuyaerts S; Van Nuffel AMT; Belmans A; Bogaerts K; Baiden-Amissah R; Lippens L; Vuylsteke P; Henry S; Trinh XB; van Dam PA; Aspeslagh S; De Caluwé A; Naert E; Lambrechts D; Hendrix A; De Wever O; Van de Vijver KK; Amant F; Vandecasteele K; Denys HG
Cancer Immunol Immunother; 2023 Feb; 72(2):475-491. PubMed ID: 35960332
[TBL] [Abstract] [Full Text] [Related]
6. Human papillomavirus (HPV) vaccination intent and its associated factors: a study of ethnically diverse married women aged 27 to 45 in Malaysia, a Southeast Asian country.
Wong LP; Alias H; Seheli FN; Zimet GD; Hu Z; Lin Y
Hum Vaccin Immunother; 2022 Nov; 18(5):2076525. PubMed ID: 35714272
[TBL] [Abstract] [Full Text] [Related]
7. Histotripsy for the Treatment of uterine Leiomyomas: A Feasibility Study in Ex Vivo uterine Fibroids.
Simon A; Robinson F; Anzivino A; Boyer M; Hendricks-Wenger A; Guilliams D; Casey J; Grider D; Valea F; Vlaisavljevich E
Ultrasound Med Biol; 2022 Aug; 48(8):1652-1662. PubMed ID: 35641394
[TBL] [Abstract] [Full Text] [Related]
8. Better Agreement of Human Transcriptomic and Proteomic cancer Expression Data at the Molecular Pathway Activation Level.
Raevskiy M; Sorokin M; Zakharova G; Tkachev V; Borisov N; Kuzmin D; Kremenchutckaya K; Gudkov A; Kamashev D; Buzdin A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269755
[TBL] [Abstract] [Full Text] [Related]
9. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract] [Full Text] [Related]
10. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract] [Full Text] [Related]
11. Structural, vibrational, quantum chemical and thermal investigation of a nutraceutical drug in new zwitterionic cocrystal form (nicotinic acid: catechol) with enhanced cytotoxic activity in cervical cancer HeLa cell line.
E AJYP; R S; K L; S A
J Biomol Struct Dyn; 2022 Aug; 40(13):5903-5916. PubMed ID: 33475027
[TBL] [Abstract] [Full Text] [Related]
12. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis.
Batman S; Bohn J; Weisenberger MW; Hersh A; Bruegl A; Caughey A; Winter W
Gynecol Oncol; 2021 Jan; 160(1):214-218. PubMed ID: 33393480
[TBL] [Abstract] [Full Text] [Related]
13. Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.
Campbell HE; Gray AM; Watson J; Jackson C; Moseley C; Cruickshank ME; Kitchener HC; Rivero-Arias O
Health Expect; 2020 Feb; 23(1):202-211. PubMed ID: 31659850
[TBL] [Abstract] [Full Text] [Related]
14. Sigmoid colon perforation after postoperative hypofractionated intensity-modulated radiation therapy in a cervical cancer patient.
Kim H; Park W; Choi YL; Lee JW
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1129. PubMed ID: 32721073
[TBL] [Abstract] [Full Text] [Related]
15. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
[TBL] [Abstract] [Full Text] [Related]
16. NTRK Fusions Define a Novel uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract] [Full Text] [Related]
17. An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis.
Lam CT; Mueller J; Asma B; Asiedu M; Krieger MS; Chitalia R; Dahl D; Taylor P; Schmitt JW; Ramanujam N
PLoS One; 2018; 13(2):e0192530. PubMed ID: 29425225
[TBL] [Abstract] [Full Text] [Related]
18. Why do we continue to overtreat stage Ia carcinoma of the cervix?
Buchanan T; Pierce JY; Graybill W; Kohler M; Creasman W
Am J Obstet Gynecol; 2017 Oct; 217(4):413-417. PubMed ID: 28522321
[TBL] [Abstract] [Full Text] [Related]
19. FISHtrees 3.0: Tumor Phylogenetics Using a Ploidy Probe.
Gertz EM; Chowdhury SA; Lee WJ; Wangsa D; Heselmeyer-Haddad K; Ried T; Schwartz R; Schäffer AA
PLoS One; 2016; 11(6):e0158569. PubMed ID: 27362268
[TBL] [Abstract] [Full Text] [Related]
20. Adjuvant effect of docetaxel on HPV16 L2E6E7 fusion protein vaccine in a mouse model.
Su X; Xu W; Guan R; Wang Y; Wu J; Zhai L; Chen G; Hu S
Int Immunopharmacol; 2016 Sep; 38():16-25. PubMed ID: 27233002
[TBL] [Abstract] [Full Text] [Related]
[Next]
